BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 4650517)

  • 1. [Study of hepatic parenchymatous function. Contribution of the galactose clearance test. Study by multidimensional statistical analysis].
    Hecht Y; Ben Amar A; Touboul JP; el-Guedry H; Salmon D; Nakache JP
    Nouv Presse Med; 1972 Dec; 1(46):3133-4. PubMed ID: 4650517
    [No Abstract]   [Full Text] [Related]  

  • 2. [Parenchymatous liver functional examination. Contribution of the intravenous galactose clearance test. Study with multidimensional statistical analyses].
    Hecht Y; Benamar A; Touboul JP; el-Guedri H; Nakache JP; Salmon D
    Med Chir Dig; 1973; 2(2):81-90. PubMed ID: 4743211
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinico-statistical evaluation of the simultaneous clearance of sulfobromophthalein and galactose in chronic liver diseases].
    Rossi L; Innocenti P; Milani A; Bombardieri G
    Quad Sclavo Diagn; 1983 Jun; 19(2):271-84. PubMed ID: 6676775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Study of hepatic function by galactose and bromosulfophthalein: their reciprocal interference].
    Spandri P; Dal Palù C; Zuin R
    Sem Hop; 1967 Sep; 43(38):2304-8. PubMed ID: 4294090
    [No Abstract]   [Full Text] [Related]  

  • 5. [Simultaneous bromsulfalein and galactose loading as a liver function test].
    Nilsson LH; Hultman E
    Nord Med; 1971 Aug; 85(31):942-3. PubMed ID: 5569721
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hepatic metabolic clearance with galactose].
    Galea G; Sdrobici D; Niţu V; Enache C
    Med Interna (Bucur); 1970 Sep; 22(9):1051-6. PubMed ID: 5491374
    [No Abstract]   [Full Text] [Related]  

  • 7. [Comparative evaluation of tolerance tests with sulfobromophthalein and with galactose in chronic liver diseases. (Value and limitations of the discriminating analyses used in the 2 tests for diagnosis of hepatic cirrhosis)].
    Coltorti M; Di Simone A; Budillon G; Carrella M; Oriani G
    Policlinico Med; 1968; 75(4):189-215. PubMed ID: 5708459
    [No Abstract]   [Full Text] [Related]  

  • 8. An intravenous galactose tolerance test with an enzymatic determination of galactose. A comparison with other diagnostic aids in hepatobiliary diseases.
    Tengström B
    Scand J Clin Lab Invest Suppl; 1966; 18():132-42. PubMed ID: 5958513
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clearance of bromsulphalein in chronic hepatitis. Anatomo-functional study in 104 cases].
    Testa R; Ciravegna G; Dodero M; Celle G
    Recenti Prog Med; 1978 Aug; 65(2):117-21. PubMed ID: 715300
    [No Abstract]   [Full Text] [Related]  

  • 10. [The validity of wofaverdin retention for the evaluation of the liver function].
    Rose W
    Dtsch Z Verdau Stoffwechselkr; 1968; 28(2):183-4. PubMed ID: 5732393
    [No Abstract]   [Full Text] [Related]  

  • 11. [Tolerance of galactose and bromsulfthalein in liver cirrhosis. A comment to a reply].
    Järnerot G
    Nord Med; 1971 Mar; 85(11):351-2. PubMed ID: 5553213
    [No Abstract]   [Full Text] [Related]  

  • 12. [Comparative evaluation of the bromsulphane test in diseases of the liver and biliary tract].
    Monastyrskaia MT; Iutanova LK; Braslavskaia GA
    Vrach Delo; 1973 Feb; 2():35-7. PubMed ID: 4722325
    [No Abstract]   [Full Text] [Related]  

  • 13. [Intravenous galactose-tolerance test in liver cirrhosis. A comparison with bromsulfalein leading].
    Järnerot G
    Nord Med; 1970 Dec; 84(50):1586-8. PubMed ID: 5519422
    [No Abstract]   [Full Text] [Related]  

  • 14. [Comparative liver function studies with high doses of BSP in intravenous galactose loading].
    Lamberts SW; Hörchner P; Birkenhäger JC
    Tijdschr Gastroenterol; 1971; 14(3):195-204. PubMed ID: 5160356
    [No Abstract]   [Full Text] [Related]  

  • 15. [Evaluation of the significance of BSF clearance in chronic post-hepatitis liver diseases].
    Camilloni R; Ghinelli F; Pizzaferri A; Pizzigoni G; Fiaccadori F
    G Clin Med; 1972 Jul; 53(7):327-33. PubMed ID: 4666410
    [No Abstract]   [Full Text] [Related]  

  • 16. [Examination of intravenous galactose loading test].
    Shiga O; Kato K; Kikuchi S
    Rinsho Byori; 1971 Aug; 19():Suppl:389. PubMed ID: 5168076
    [No Abstract]   [Full Text] [Related]  

  • 17. [Physiopathological and clinical significance of hepatocyte (S) accumulation and maximum transport (M+) of BSF in hepatic cirrhosis and in chronic hepatitis: correlations with sinusoidal flow].
    Di Simone A; Gentile S; Riegler G; Coltorti M
    Boll Soc Ital Biol Sper; 1973 Dec; 49(23):1411-4. PubMed ID: 4803108
    [No Abstract]   [Full Text] [Related]  

  • 18. A comparison of the bromsulphthalein and galactose elimination test in patients with either chronic bowel inflammation or alcoholic liver disease.
    Nilsson LH; Hultman E
    Scand J Gastroenterol; 1974; 9(3):319-23. PubMed ID: 4850181
    [No Abstract]   [Full Text] [Related]  

  • 19. [The oral galactose tolerance as a liver function test. Clinical-experimental studieson the prolem of dosage].
    Rommel K; Grimmel K
    Med Klin; 1967 Feb; 62(5):168-71. PubMed ID: 5590185
    [No Abstract]   [Full Text] [Related]  

  • 20. [Evaluation of the liver function with the aid of bromsulphalein and vofaverdin].
    Geller LI; Bulgakova OS; Griaznova MV; Ozherel'eva NIa
    Vrach Delo; 1978 Jun; (6):78-81. PubMed ID: 695480
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.